Dominik Selleslag, Dominik

dr. Dominik Selleslag

Hematologie

» Contactgegevens op ziekenhuiswebsite

Publicaties [ 31 resultaten ]

Targeted next generation DNA sequencing for the detection of clonal haematopoiesis in idiopathic cytopaenia of undetermined significance (ICUS).

BELG J HAEMATOL 2019;10(6):231-40
01/01/2019

Targeted next generation DNA sequencing for the detection of clonal haematopoiesis in idiopathic cytopaenia of undetermined significance (ICUS).

Belgian Journal of Hematology 2019;10:231-40
01/01/2019

Targeted next generation DNA sequencing for the detection of clonal haematopoiesis in idiopathic cytopaenia of undetermined significance (ICUS).

Belgian Journal of Hematology 2019;10:231-40
01/01/2019

Postuniversitair Centrum KUL campus West-Vlaanderen, Postacademische cyclus geneeskunde. Aanwinsten in de oncologie en haematologie. Dr. Ann Janssens en Dr. Timothy Devos. Nieuwe ontwikkelingen bij CLL, CML en MGUS.

09/02/2010

» http://www.ncbi.nlm.nih.gov/sites/

Belgian Hematological Society 29 en 30.01.10, te Oostende. – Is there an increased incidence of plasmablastic transformation in multiple myeloma after treatment with Imids and bortezomib?

Oostende, Belgium
29/01/2010

» http://www.ncbi.nlm.nih.gov/sites/

Posterabstract Belgian Hematological Society 29 en 30.01.10, te Oostende.Mixed phenotype acute leukaemia with MLL/AF4 rearrangement: A case report with sudden lineage switch.

Oostende, Belgium
29/01/2010

» http://www.ncbi.nlm.nih.gov/sites/

American society of haematology, New Orleans, USA. Value of Low Dose IL-2 as Maintenance Following Consolidation Treatment or Autologous Transplantation in Acute Myelogenous Leukemia (AML) Patients Aged 15-60 Years Who Reached CR After High Dose (HD-AraC) Vs Standard Dose (SD-AraC) Cytosine Arabinoside During Induction: Results of the AML-12 Trial of EORTC and GIMEMA Leukemia Groups.

05/12/2009

» http://www.ncbi.nlm.nih.gov/sites/

American Society of Haematology, New Orleans, USA. RBC Transfusion Independence and Safety Profile of Lenalidomide 5 or 10 mg in Pts with Low- or Int-1-Risk MDS with Del5q: Results From a Randomized Phase III Trial (MDS-004) .

05/12/2009

» http://www.ncbi.nlm.nih.gov/sites/

American Society of Haematology, New Orleans, USA. Comparison of Splenectomy and Treatment Failure Incidence in Nonsplenectomized Patients with Immune Thrombocytopenia (ITP) Receiving Romiplostim or Medical Standard of Care: 1-Year Treatment and 6-Month Safety Follow-up.

05/12/2009

» http://www.ncbi.nlm.nih.gov/sites/

Postuniversitair Centrum KUL campus West-Vlaanderen. Recente vooruitgang in Alzheimeronderzoek suggereert mogelijkheden tot therapie. Prof Dr. Bart De Strooper

18/11/2009

» http://www.ncbi.nlm.nih.gov/sites/

Farewell celebration of Prof dr Georges Fillet. CHU Sar Tilman, Liège. Past, present and future in the treatment of acute myeloid leukemia. An EORTC perspective.

05/09/2009

» http://www.ncbi.nlm.nih.gov/sites/

Assistentenvereniging Klinische Biologie (FAKB), KULeuven, UZ Gasthuisberg. Klinische aspecten en huidige therapie voor acute myeloide leukemie.

27/06/2009

» http://www.ncbi.nlm.nih.gov/sites/

V European Haematology Association 2009, Berlijn. Efficacy and safety of romiplostim vs medical standard of care as chronic therapy for nonsplenectomized patients with immune thrombocytopenia.

04/06/2009

» http://www.ncbi.nlm.nih.gov/sites/

V European Haematology Association 2009, Berlijn. The use of iron chelation thearpy for transfusion dependent myelodysplastic syndrome patients: a cross sectional study in Belgium.

04/06/2009

» http://www.ncbi.nlm.nih.gov/sites/

Celgene 2nd MDS Colloquium, Barcelona, Palau de Congressos de Catalunya, Workshop on Clinical use of Vidaza in Myelodysplastic syndromes.

15/04/2009

» http://www.ncbi.nlm.nih.gov/sites/

Acute thyrotoxicosis after SCT.

Bone Marrow Transplant. 2009 Apr;43(8):663-4. Epub 2008 Nov 17. No abstract available. PMID: 19011663 [PubMed - indexed for MEDLINE] PMID: 17986280
01/04/2009

Belgian Haematological Society, Oostende. Economic evaluation of voriconazole versus caspofungin for the treatment of invasive aspergillosis in Belgium.

30/01/2009

» http://www.ncbi.nlm.nih.gov/sites/

24 th meeting of Belgian Haematological Society, Thermae Palace Oostende. Amgen Satellite Symposium. “Update on romiplostim trials in ITP”.

30/01/2009

» http://www.ncbi.nlm.nih.gov/sites/

Clinical challenges and images in GI. Fasciola hepatica infection and Von Hippel-Lindau disease type 1 with pancreatic and renal involvement.

Gastroenterology 2007;132:15-6, 467-8.
01/01/2007

» http://www.ncbi.nlm.nih.gov/pubmed/
Toon meer